Favipiravir
Pharmaceutical-grade Favipiravir (T-705, CAS 259793-96-9), min. 99%, supplied wholesale by Zyntex to licensed producers. RNA polymerase inhibitor API for tablets in markets where it is authorized. CoA and SDS with every lot.
Description
Favipiravir Product Overview
Favipiravir (C5H4FN3O2) is a white to light yellow crystalline powder. It is a pyrazinecarboxamide derivative that cells convert into an active form, which inhibits viral RNA polymerase.
In addition, pharmaceutical companies use it in film-coated tablets. In Japan, it was approved for novel or re-emerging influenza under special conditions, and several other countries authorized it for other viral infections, whereas many regulators, including the EU and the United States, did not approve it. Because it showed harmful effects on unborn animals, its use requires strict precautions.
Buyers must therefore check the regulatory status in their market. Other antiviral APIs in our range also include Remdesivir and Molnupiravir. Zyntex supplies favipiravir only to licensed pharmaceutical companies.
Key Applications of Favipiravir
Typical uses include, for example:
💊 Tablets
API for film-coated tablets in authorized markets.
🏥 Pandemic Preparedness
API for stockpiles where authorized.
🔬 Generic Development
Development as well as reference material.
🧪 Research
Reference compound for antiviral studies.
Favipiravir Technical Specifications
| Parameter | Standard Value |
|---|---|
| Product Name | Favipiravir (T-705) |
| CAS Number | 259793-96-9 |
| Molecular Formula / Weight | C5H4FN3O2 / 157.10 g/mol |
| Assay / Purity | Min. 99.0% |
| Appearance | White to light yellow crystalline powder |
| Documents | CoA as well as SDS with every lot |
⚠️ Safety & Handling: Pharmacologically active substance that may damage the unborn child. Handle in contained systems, and also wear gloves, eye protection and respiratory protection. Store in tightly closed containers in a cool, dry place. Always consult the Safety Data Sheet (SDS), because it contains the full classification and handling instructions.
Frequently Asked Questions
Does favipiravir have approval everywhere?
No. It remains authorized in Japan under special conditions and in some other countries, whereas regulators such as the EU and the United States did not approve it.
Who can purchase this API?
Only pharmaceutical companies holding the licenses required for API purchase as well as use in their country.
How can I get a price and documents?
Prices depend on quantity, packaging and destination, so please contact us with your required volume. We then send a quotation together with the CoA and SDS.
